# Cosmetic Stability Testing: Planning the Study and Keeping Useful Records

> Plan a product-specific cosmetic stability study and connect formula versions, packaging, samples, measurements, deviations, and conclusions.

Canonical URL: https://cosmeticaffairs.com/blogs/cosmetic-chemistry/cosmetic-stability-testing-records/

Author: [Cosmetic Affairs Editorial](https://cosmeticaffairs.com/authors/editorial/)
Published: 2026-10-17T00:00:00-04:00
Modified: 2026-10-17T00:00:00-04:00
Collection: Cosmetic Chemistry
Topics: Stability Testing, Formulation, Quality Control

![A technician compares cream samples beside an environmental chamber and retained study containers.](https://cosmeticaffairs.com/blogs/cosmetic-chemistry/cosmetic-stability-testing-records/cover.png)

AI-generated illustration; not a photograph of actual laboratory work.

A stability study should leave a team able to explain what it tested, what changed, and why the results support its decision. A folder of photographs and a spreadsheet marked “pass” may leave important questions unresolved, particularly when formulas, packaging or methods change during development.

The useful starting point is a written study plan linked to a defined product. From there, the work becomes easier to organise: assign samples, establish methods, record observations and review the evidence against an agreed question.

## Define the decision the study needs to support

Is the team screening early prototypes, comparing packages, investigating a change or supporting a proposed product life? Each purpose needs to be explicit because the evidence suitable for one decision may be insufficient for another.

ISO/TR 18811 provides a framework for identifying suitable approaches to cosmetic stability testing. It deliberately does not prescribe universal test conditions, parameters or acceptance criteria. The manufacturer needs to specify and justify a protocol appropriate to the product.[^1]

Write the objective in a sentence a colleague can understand. For example: “Evaluate whether formula F-218 version 4 remains within the proposed quality criteria in package P-07 under the justified study conditions.” Add the study owner, reviewer, planned start and the decision that will follow.

Also state what this phase will not resolve. If commercial-scale confirmation or further packaging work remains outstanding, record that as a planned activity with an owner. This prevents an early development result from silently becoming the evidence for a broader conclusion.

## Match the samples to the product and package

Keep a clear relationship between the formula, the batch actually prepared and each sample placed on study. Give samples identifiers that remain readable and distinguish the package, storage condition and intended assessment point.

Cosmetics Europe's stability guidance addresses the product and its packaging together. It also discusses the relevance of manufacturing scale and recommends real-time follow-up to support predictions from accelerated work.[^2]

A practical sample record can therefore include the formula version, batch reference, preparation date, packaging specification, filling details and quantity. Where a prototype differs from the intended commercial product, describe the difference and its implications for the current study objective.

Plan sample quantities before starting. Consider whether an assessment consumes the sample or changes its subsequent history, and whether separate units are needed for other work. If a sample is replaced, relabelled or moved, preserve the original reference and the reason. A tidy shelf should not conceal an uncertain sample history.

## Choose measurements that can answer the question

Select properties and methods appropriate to the product. Potential observations include appearance, odour, pH, viscosity, package condition and relevant analytical or microbiological measures. Cosmetics Europe's examples are considerations for study design, rather than a mandatory checklist for every cosmetic.[^2]

For each selected property, define how it will be measured and how the result will be assessed. “Viscosity acceptable” is difficult to review without a method, units and an acceptance basis. For a visual assessment, specify what the observer should look for and how photographs will be taken so comparisons remain useful.

Record the baseline before drawing conclusions about change. Keep measurement conditions consistent where comparison requires it, and identify the instrument and method revision used. If the method changes during the study, document how the new results relate to the earlier ones.

Set criteria before reviewing the outcome. If new knowledge justifies revising them, preserve both versions and the reason for the change. Moving a limit after seeing an inconvenient result requires a transparent scientific justification.

## Make the record usable at every assessment point

The following is a suggested record structure to adapt to the study. It is not a prescribed regulatory form.

| Record element | What it helps someone reconstruct |
| --- | --- |
| Study, formula, batch and sample references | Which material the observation concerns |
| Planned assessment point and actual date | Whether timing followed the plan |
| Storage location and relevant condition history | What the sample experienced |
| Method, equipment and result with units | How the observation was produced |
| Photograph or original data reference | Where the supporting evidence is held |
| Observer, reviewer and review date | Who performed and assessed the work |
| Deviation, decision and next action | How an unexpected event was handled |

Separate “not yet measured” from “no change observed.” The first describes missing work; the second is an observation. Likewise, a result awaiting review should remain distinguishable from an accepted result.

Give entries enough context to stand alone. A future reviewer may not know the shorthand used by the person who ran the study or remember a conversation about the incubator.

## Investigate changes without losing the original evidence

Illustrative example: an analyst notices that one lotion sample dispenses unevenly from its pump. The appearance of the lotion in a separate observation container seems unchanged.

The record should describe both observations and identify the units involved. The team might examine the pump, review the package specification and compare other stored units. It should avoid replacing the original entry with “product stable” simply because a second sample dispenses normally.

Record the question being investigated, who owns it, the additional work and the resulting interpretation. If an equipment excursion occurred, assess which samples and time periods it affected. Explain whether existing data remain useful, additional observations are needed or part of the study requires repetition.

The same discipline applies to a late assessment or an incorrectly stored sample. Preserve what happened and make a proportionate decision about its effect. The record should show how the issue was resolved, including any remaining limitation on the study conclusion.

## Write a conclusion with a defined scope

The report should identify the tested product, summarise relevant trends, explain deviations and state the conclusion supported at that stage. Separate observed results from predictions, and document the basis for any extrapolation. There is no universal conversion by which a fixed short accelerated study automatically proves several years of shelf life.[^1][^2]

FDA describes cosmetic shelf life as dependent on the product, its use and storage. It also identifies determining shelf life as part of the manufacturer's responsibility.[^3]

Keep the signed or approved conclusion connected to its supporting records, and identify any follow-up still due. When a formula, package or process changes, the team can then assess the relevance of the existing evidence from a documented starting point.

## Sources

[^1]: International Organization for Standardization. [ISO/TR 18811:2018: Guidelines on the stability testing of cosmetic products](https://www.iso.org/standard/63465.html). Public scope and available preview.

[^2]: Cosmetics Europe and CTFA. [Guidelines on Stability Testing of Cosmetic Products, March 2004](https://cosmeticseurope.eu/wp-content/uploads/2024/10/Guidelines_on_Stability_Testing_of_Cosmetics_CE-CTFA_-_2004.pdf). Industry guidance published in March 2004.

[^3]: US Food and Drug Administration. [Shelf Life and Expiration Dating of Cosmetics](https://www.fda.gov/cosmetics/cosmetics-labeling/shelf-life-and-expiration-dating-cosmetics).